Novo Nordisk

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit

Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today’s business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance. In 2013, Novo Nordisk received the Pharmaceuticals and Biotechnology industry group top ranking on Corporate Knight’s list of Global 100 Most Sustainable Corporations. For more information, visit



The TBL Quarterly
Novo Nordisk's TBL Quarterly tells the actions, challenges and opportunities of conducting a sustainable business. Each quarterly issue offers...

Novo Nordisk's Sustainable Value Creation
Sustainable value creation is a core business strategy focused on addressing fundamental societal issues that provide community benefit, are scalable...

Novo Nordisk involvement in Rio at the United Nations Conference on Sustainable Development
Novo Nordisk aims to engage, contribute and share best practices to support positive outcomes at the UN Conference on Sustainable Development in Rio...


Contact Novo Nordisk